Squarepoint Ops LLC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1642575 NEW YORK, NY

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,619,162

+$1,710,698 QoQ

Shares Held

295,824

+22.7% QoQ

Ownership

0.674%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#35

of 256 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. TARS ranks #16 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,619,162	295,824	+22.7%	Shares	Defined	2026-08-14
2026-03-31	$16,908,464	241,033	+1004.0%	Shares	Defined	2026-05-15
2025-12-31	$1,787,686	21,833	-73.2%	Shares	Defined	2026-02-13
2025-09-30	$4,842,296	81,479	-20.6%	Shares	Defined	2025-11-14
2025-06-30	$4,158,027	102,642	+78.0%	Shares	Defined	2025-08-27
2025-03-31	$2,961,788	57,656	+860.3%	Shares	Defined	2025-08-27
2024-12-31	$332,441	6,004	-89.5%	Shares	Defined	2025-02-14
2024-09-30	$1,885,682	57,333	+69.3%	Shares	Defined	2024-11-14
2024-03-31	$1,231,065	33,867	+75.1%	Shares	Defined	2024-05-15
2023-09-30	$343,742	19,344	+92.7%	Shares	Defined	2023-11-14
2023-06-30	$181,440	10,041	-28.0%	Shares	Defined	2023-08-14
2023-03-31	$175,188	13,937	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.